Literature DB >> 2495536

Characterization of a presecretory phase in B-cell differentiation.

L B King1, R B Corley.   

Abstract

We have identified and characterized an inducible in vitro subclone of the CH12 B-cell lymphoma, CH12-LBK, which appears to represent a transitional phase in the B-cell differentiation pathway. This phase, which we call the "presecretory" phase, falls between replicating B cells that are not secreting antibodies and B cells that secrete antibody at a high rate. Presecretory cells are characterized by abundant steady-state levels of immunoglobulin and joining (J) chain transcripts and of protein but low levels of mouse mammary tumor virus envelope transcripts and low rates of immunoglobulin secretion. Additional stimulation is required for presecretory cells to differentiate into cells that secrete antibodies at a high rate. The existence of cells with this phenotype suggests that high-level expression of immunoglobulin and J-chain protein does not necessarily commit a B cell to polymerize and secrete multimeric immunoglobulin. Rather, other gene products, expressed after immunoglobulin and J-chain transcripts have been upregulated late in B-cell differentiation, appear responsible for inducing high rates of antibody secretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495536      PMCID: PMC287009          DOI: 10.1073/pnas.86.8.2814

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells.

Authors:  U Schibler; K B Marcu; R P Perry
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

2.  Modification and fate of J chain in myeloma cells in the presence and absence of polymeric immunoglobulin secretion.

Authors:  T R Mosmann; Y Gravel; A R Williamson; R Baumal
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

3.  Surface alloantigens of plasma cells.

Authors:  T Takahashi; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

4.  The sequence at the 3' terminus of mouse immunoglobulin secreted mu chain messenger RNA determined from cloned cDNA.

Authors:  G Matthyssens; T H Rabbitts
Journal:  Nucleic Acids Res       Date:  1980-02-25       Impact factor: 16.971

5.  B lymphocyte differentiation and the control of IgM mu chain expression.

Authors:  C Sidman
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

6.  Identification of a lymphocyte enzyme that catalyzes pentamer immunoglobulin M assembly.

Authors:  R A Roth; M E Koshland
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

7.  Molecular events during B lymphocyte differentiation. Induction of endogenous mouse mammary tumor proviral envelope transcripts after B cell stimulation.

Authors:  S Sharma; L B King; R B Corley
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

8.  Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability.

Authors:  T Mosmann; R Baumal
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

9.  Electrophoretic heterogeneity of polypeptide chains of specific antibodies.

Authors:  R A Reisfeld; P A Small
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

10.  IgM-producing tumors in the BALB-c mouse: a model for B-cell maturation.

Authors:  J Andersson; J Buxbaum; R Citronbaum; S Douglas; L Forni; F Melchers; B Pernis; D Stott
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  11 in total

1.  VAMP2 is implicated in the secretion of antibodies by human plasma cells and can be replaced by other synaptobrevins.

Authors:  Laura Gómez-Jaramillo; Raquel Romero-García; Gema Jiménez-Gómez; Lisa Riegle; Ana Belén Ramos-Amaya; José Antonio Brieva; Marie Kelly-Worden; Antonio Campos-Caro
Journal:  Cell Mol Immunol       Date:  2016-09-12       Impact factor: 11.530

2.  Cytokine-induced differentiation of IgA B cells: studies using an IgA expressing B-cell lymphoma.

Authors:  L Eckmann; E Morzycka-Wroblewska; J R Smith; M F Kagnoff
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

3.  Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways.

Authors:  L B King; R B Corley
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation.

Authors:  T D Randall; F E Lund; J W Brewer; C Aldridge; R Wall; R B Corley
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

5.  J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.

Authors:  T D Randall; R M Parkhouse; R B Corley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

6.  Membrane biogenesis during B cell differentiation: most endoplasmic reticulum proteins are expressed coordinately.

Authors:  D L Wiest; J K Burkhardt; S Hester; M Hortsch; D I Meyer; Y Argon
Journal:  J Cell Biol       Date:  1990-05       Impact factor: 10.539

7.  Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences.

Authors:  A J Feeney
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

8.  Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor.

Authors:  D L Woodland; H P Smith; S Surman; P Le; R Wen; M A Blackman
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

9.  Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage.

Authors:  F E Lund; R B Corley
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma.

Authors:  Dalia Quwaider; Luis A Corchete; Irena Misiewicz-Krzeminska; María E Sarasquete; José J Pérez; Patryk Krzeminski; Noemí Puig; María Victoria Mateos; Ramón García-Sanz; Ana B Herrero; Norma C Gutiérrez
Journal:  J Hematol Oncol       Date:  2017-04-18       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.